Figure 2 | Scientific Reports

Figure 2

From: Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer

Figure 2

ERG expression and validation of a novel fusion transcript. (A) Expression levels of 3′-part of ERG and presence of TMPRSS2-ERG in individual prostate cancer and benign tissue samples. Orange: TMPRSS2-ERG, Blue: ENSG00000263427-ERG, Green: no detected fusion. (B) Identification of a novel fusion transcript consisting of a region antisense to the long non-coding RNA ENSG00000263427 (Ensembl GRCh38; Chr. 17: 8,057,149) and exon 2 of ERG (ENSE00003712731; Chr. 21: 38,445,621).

Back to article page